Home Cart Sign in  
Chemical Structure| 149709-62-6 Chemical Structure| 149709-62-6

Structure of Sacubitril
CAS No.: 149709-62-6

Chemical Structure| 149709-62-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AHU-377 and valsartan can compose LCZ696 in a 1:1 molar ratio. It also works as an inhibitor of neprilysin with IC50 value of 5 nM.

Synonyms: AHU-377

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sacubitril

CAS No. :149709-62-6
Formula : C24H29NO5
M.W : 411.49
SMILES Code : O=C(O)CCC(N[C@@H](C[C@@H](C)C(OCC)=O)CC1=CC=C(C2=CC=CC=C2)C=C1)=O
Synonyms :
AHU-377
MDL No. :MFCD00920862
InChI Key :PYNXFZCZUAOOQC-UTKZUKDTSA-N
Pubchem ID :9811834

Safety of Sacubitril

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Sacubitril

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01601470 Mild to Moderate Hypertension Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 14050 Less <<
NCT01569815 Mild and Moderate Renal Impair... More >>ment Less << Phase 1 Completed - Germany ... More >> Novartis Investigative Site Neuss, Germany, 41460 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 117292 Serbia Novartis Investigative Site Belgrade, Serbia Less <<
NCT01621633 Hepatic Impairment Phase 2 Completed - Germany ... More >> Novartis Investigative Site Grunstadt, Germany, D-67269 Less <<
NCT01569815 - Completed - -
NCT01601470 - Completed - -
NCT00549770 Hypertension Phase 2 Completed - -
NCT01281306 Systolic Hypertension Phase 2 Completed - -
NCT00549770 - Completed - -
NCT01621633 - Completed - -
NCT01281306 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.43mL

0.49mL

0.24mL

12.15mL

2.43mL

1.22mL

24.30mL

4.86mL

2.43mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories